Formulation of a protein with propellant HFA 134a for aerosol delivery

By Williams III R.O.   Liu J.  

European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 2, 1999-01 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite

Development of an Omeprazole Parenteral Formulation with Hydroxypropyl-β-Cyclodextrin

By Holvoet Chantal   Heyden Yvan Vander   Plaizier-Vercammen Jacqueline  

Pharmaceutical Development and Technology, Vol. 12, Iss. 3, 2007-05 ,pp. : 327-336

Informa Healthcare

Access to resources Recommend Favorite

The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl- -cyclodextrin

By Mura P.   Faucci M.T.   Bettinetti G.P.  

European Journal of Pharmaceutical Sciences, Vol. 13, Iss. 2, 2001-05 ,pp. : 187-194

Elsevier

Access to resources Recommend Favorite

Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique

By Chen Zhongjian   Lu Yi   Qi Jianping   Wu Wei  

Pharmaceutical Development and Technology, Vol. 18, Iss. 1, 2013-02 ,pp. : 130-136

Informa Healthcare

Access to resources Recommend Favorite

Considerations in the use of hydroxypropyl- -cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone

By Bary A.R.   Tucker I.G.   Davies N.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 237-244

Elsevier

Access to resources Recommend Favorite